1
|
Chappell AG, Bai J, Yuksel S, Ellis MF. Post-Mastectomy Pain Syndrome: Defining Perioperative Etiologies to Guide New Methods of Prevention for Plastic Surgeons. World J Plast Surg 2020; 9:247-253. [PMID: 33329999 PMCID: PMC7734930 DOI: 10.29252/wjps.9.3.247] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Abstract
From discussing the etiologies of post-mastectomy pain syndrome and potential methods of prevention, the next step is to create specific methods of prevention and to identify ways to measure their effects. With the increase in breast cancer related surgeries and increased survival after breast cancer patients, efforts must be made to prevent chronic pain and improve quality of life for these patients after surgery. The plastic surgeon, skilled in breast reconstruction and peripheral nerve reconstruction, may play a significant role in eliminating chronic pain after breast cancer related surgery.
Collapse
Affiliation(s)
- Ava G Chappell
- Division of Plastic and Reconstructive Surgery, Northwestern Medicine, Feinberg School of Medicine, Chicago, IL, USA
| | - Jennifer Bai
- Division of Plastic and Reconstructive Surgery, Northwestern Medicine, Feinberg School of Medicine, Chicago, IL, USA
| | - Selcen Yuksel
- Division of Plastic and Reconstructive Surgery, Northwestern Medicine, Feinberg School of Medicine, Chicago, IL, USA
| | - Marco F Ellis
- Division of Plastic and Reconstructive Surgery, Northwestern Medicine, Feinberg School of Medicine, Chicago, IL, USA
| |
Collapse
|
2
|
Cui L, Fan P, Qiu C, Hong Y. Single institution analysis of incidence and risk factors for post-mastectomy pain syndrome. Sci Rep 2018; 8:11494. [PMID: 30065342 PMCID: PMC6068100 DOI: 10.1038/s41598-018-29946-x] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2018] [Accepted: 07/19/2018] [Indexed: 11/16/2022] Open
Abstract
Post Mastectomy Pain Syndrome (PMPS) is a common postoperative condition for breast cancer, but has been ignored. The aim of this study was to investigate the prevalence of PMPS and the risk factors in women submitted to surgical treatment for breast cancer. The study included 532 postoperative breast cancer patients in a hospital for five consecutive years period, of whom 473 were considered eligible and included in the study. A total of 420 people completed a questionnaire survey, which revealed that 152 (36.2%) had ever suffered from PMPS and 18 (11.8%) sought treatment. Of the patients with PMPS, 34 (22.4%) had a history of chronic pain. Patients with PMPS were younger than patients without PMPS (50.5 ± 10.4 vs 53.5 ± 11.1). Univariate analysis showed that age, history of chronic pain, tumor staging, number of lymphadenectomy were significantly different between the two groups. Multivariate analysis shows that age and history of chronic pain were independent risk factors. The incidence of PMPS in postoperative breast cancer patients can reach 36.2%, and age as well as previous history of pain are independent risk factors for PMPS. The combination of prevention and treatment may be an effective way to reduce PMPS.
Collapse
Affiliation(s)
- Lingfei Cui
- Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guangxi Zhuang Autonomous Region Second People's Hospital, Breast surgery, Guilin, Guangxi, China
| | - Ping Fan
- Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guangxi Zhuang Autonomous Region Second People's Hospital, Breast surgery, Guilin, Guangxi, China
| | - Chaoxue Qiu
- Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guangxi Zhuang Autonomous Region Second People's Hospital, Breast surgery, Guilin, Guangxi, China
| | - Yong Hong
- Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guangxi Zhuang Autonomous Region Second People's Hospital, Breast surgery, Guilin, Guangxi, China.
| |
Collapse
|
3
|
Spear SL, Coles CN, Leung BK, Gitlin M, Parekh M, Macarios D. The Safety, Effectiveness, and Efficiency of Autologous Fat Grafting in Breast Surgery. PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN 2016; 4:e827. [PMID: 27622095 PMCID: PMC5010318 DOI: 10.1097/gox.0000000000000842] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2016] [Accepted: 06/08/2016] [Indexed: 01/15/2023]
Abstract
Background: For years, the safety and effectiveness of autologous fat grafting (AFG) for breast reconstruction have been in question, with particular concern over fat necrosis, calcifications, cyst formation, and interfering with the detection of breast cancer. However, increasing evidence suggests that the complication rates and clinical results are generally acceptable to both clinicians and patients. The emerging challenge is the numerous AFG techniques and systems, where there are limited knowledge and data. The objective of this study was to conduct a literature review that focuses on the safety, effectiveness, and efficiency of various AFG techniques as applied to the breast. Methods: A PubMed search using terms related to AFG was performed over a 5-year period (April 1, 2010–April 30, 2015). Original articles focused on AFG to the breast, with outcomes on safety, effectiveness, and efficiency, were included. Results: Five hundred ninety-eight articles were identified with 36 articles included (n = 4306 patients). Satisfaction rates were high although the prevalence of complications was low—similar to previous findings. Seven studies reported average operating room time with an overall mean of 125 minutes (range: 40–210). The mean volume of fat harvested was 558 mL (range: 120–1299), and fat injected was 145 mL (range: 20–607). A positive association between injection volume and operating time was observed. Conclusions: This review validates previous findings on the safety and effectiveness of AFG to the breast and highlights its efficiency. The efficiency data available, although limited, suggest that there is an opportunity to achieve time and cost savings while not sacrificing safety and effectiveness.
Collapse
Affiliation(s)
- Scott L Spear
- Georgetown University Hospital, Washington, D.C.; BluePath Solutions, Santa Monica, Calif.; and Acelity, Bridgewater, N.J
| | - Courtney N Coles
- Georgetown University Hospital, Washington, D.C.; BluePath Solutions, Santa Monica, Calif.; and Acelity, Bridgewater, N.J
| | - Braden K Leung
- Georgetown University Hospital, Washington, D.C.; BluePath Solutions, Santa Monica, Calif.; and Acelity, Bridgewater, N.J
| | - Matthew Gitlin
- Georgetown University Hospital, Washington, D.C.; BluePath Solutions, Santa Monica, Calif.; and Acelity, Bridgewater, N.J
| | - Mousam Parekh
- Georgetown University Hospital, Washington, D.C.; BluePath Solutions, Santa Monica, Calif.; and Acelity, Bridgewater, N.J
| | - David Macarios
- Georgetown University Hospital, Washington, D.C.; BluePath Solutions, Santa Monica, Calif.; and Acelity, Bridgewater, N.J
| |
Collapse
|
4
|
Huang SH, Wu SH, Chang KP, Lin CH, Chang CH, Wu YC, Lee SS, Lin SD, Lai CS. Alleviation of neuropathic scar pain using autologous fat grafting. Ann Plast Surg 2016; 74 Suppl 2:S99-104. [PMID: 25695456 DOI: 10.1097/sap.0000000000000462] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Traumatic wounds inflict small- and large-fiber sensory nerve damage, causing neuropathic pain in scar tissue, thus impairing patients' quality of life and leading to the development of psychological disorders. Autologous fat grafting has been clinically shown to improve scar quality, but few studies have explored the effects of this technique on pain. The purpose of this study was to assess the effect of fat grafting on treating neuropathic scar pain. From February 2008 to January 2013, 13 patients who were identified using the Douleur Neuropathique 4 Questions (scores>4/10) were enrolled in this study. The Visual Analog Scale (VAS) and Neuropathic Pain Symptom Inventory (NPSI) were used to evaluate pain preoperatively and 1 week, 4 weeks, and 24 weeks postoperatively. The mechanism of trauma, scar location and size, duration of allodynia, fat graft volume, pharmacologic therapy duration, and total follow-up time were recorded. Thirteen patients experiencing neuropathic pain were enrolled in this study. The mean±SD age was 33.08±16.35 years. The mean duration of pain was 4.29±2.85 months. The mean VAS score before treatment was 7.54±1.05. The mean VAS scores decreased by 4.38±1.66 after 1 week of treatment (P=0.009), 5.38±2.06 after 4 weeks of treatment, and 5.62±2.18 after 24 weeks of treatment. The mean NPSI scores were 49.38±13.25 before treatment, 25±14.4 after 1 week of treatment (P=0.004), 21±17.78 after 4 weeks of treatment, and 14.62±16.88 after 24 weeks of treatment. The 13 patients followed a mean of 24 weeks; 10 (77%) of the patients had improvement of 5 or greater on the VAS score. The mean follow-up period was 19.3±12.26 months (range, 6-38 months). No surgical complications were noted in this series. In our study, both VAS and NPSI scores decreased significantly, revealing that the autologous fat grafting can alleviate neuropathic scar pain 1 week after operation and in the long term.
Collapse
Affiliation(s)
- Shu-Hung Huang
- From the *Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, †Division of Plastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, ‡Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, §Center for Stem Cell Research, Kaohsiung Medical University, Kaohsiung, Taiwan, and ∥Department of Anesthesia, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
| | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Simorre M, Chaput B, Voglimacci Stephanopoli M, Garrido I, Soule-Tholy M, Leguevaque P, Vaysse C. [Lipofilling in breast reconstruction: is there any population with higher risk of local recurrence? Literature systematic review]. ACTA ACUST UNITED AC 2015; 43:309-18. [PMID: 25813431 DOI: 10.1016/j.gyobfe.2015.02.003] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2014] [Accepted: 02/18/2015] [Indexed: 12/13/2022]
Abstract
Safety of the autologous fat grafting (AFG) in the breast parenchyma remains a debated topic, particularly in reconstruction following breast cancer. This procedure still raises many questions, especially considering recent in vitro studies warning about the fact that lipofilling could promote tumor recurrence through increased neoangiogenesis, or facilitate metastasis. Through a systematic literature review on oncological risk and radiological follow-up, conducted from January 2010 to August 2014, we tried to identify populations at risk of recurrence after AFG. The study selection process was adapted from the Prisma statement. Out of the seven analysed patients cohorts, i.e. approximately 1500 AFG procedures, results on the risk of local recurrence appear reassuring after an average follow-up of 42 months. These results should be cautiously interpreted because of the heterogeneity of the studies. However, recurrences have been analysed based on the characteristics of the original tumor and many of them warn about population that seem more at risk of recurrence. Studies on radiological modifications after AFG emphasize the need for the radiologists to know the importance of radiological images induced by this procedure, however, AFG does not seem to interfere with radiological screening of local recurrence. In order to deliver clear information to patients receiving breast reconstruction by lipofilling, prospective studies focused on populations that seem to be most at risk of recurrence are required.
Collapse
Affiliation(s)
- M Simorre
- Service de chirurgie générale et gynécologique oncologique, CHU-Hôpital Rangueil, 1, avenue Professeur Jean-Poulhès, 31056 Toulouse cedex 9, France.
| | - B Chaput
- Service de chirurgie plastique, reconstructrice et esthétique, CHU-Hôpital Rangueil, 1, avenue Professeur Jean-Poulhès, 31056 Toulouse cedex 9, France
| | - M Voglimacci Stephanopoli
- Service de chirurgie générale et gynécologique oncologique, CHU-Hôpital Rangueil, 1, avenue Professeur Jean-Poulhès, 31056 Toulouse cedex 9, France
| | - I Garrido
- Service de chirurgie plastique, reconstructrice et esthétique, CHU-Hôpital Rangueil, 1, avenue Professeur Jean-Poulhès, 31056 Toulouse cedex 9, France
| | - M Soule-Tholy
- Service de chirurgie générale et gynécologique oncologique, CHU-Hôpital Rangueil, 1, avenue Professeur Jean-Poulhès, 31056 Toulouse cedex 9, France
| | - P Leguevaque
- Service de chirurgie générale et gynécologique oncologique, CHU-Hôpital Rangueil, 1, avenue Professeur Jean-Poulhès, 31056 Toulouse cedex 9, France
| | - C Vaysse
- Service de chirurgie générale et gynécologique oncologique, CHU-Hôpital Rangueil, 1, avenue Professeur Jean-Poulhès, 31056 Toulouse cedex 9, France
| |
Collapse
|